# KP Pharmaceutical Technology - Inspection Records

Source: https://www.keypedia.com/companies/kp-pharmaceutical-technology/acd7d203-2bd2-4702-a902-83c45f57890f

> Inspection records and compliance data for KP Pharmaceutical Technology in Bloomington, Indiana. Access full analysis and detailed observations.

---

## Details

- Name: KP Pharmaceutical Technology
- FEI Number: 3001802820
- City: Bloomington
- State: Indiana
- Country Name: United States
- Address Line 1: 1212 W Rappel Ave
- Zip Code: 47404
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [FDA Inspection 1307874 - KP Pharmaceutical Technology - 2026-02-13](https://www.keypedia.com/records/fda_inspections/kp-pharmaceutical-technology/86f3f41c-36c0-4599-8c5f-bf64f6e61ae2) — source: FDA, date: February 13, 2026
- [FDA Inspection 1307874 - KP Pharmaceutical Technology - 2026-02-13](https://www.keypedia.com/records/fda_inspections/kp-pharmaceutical-technology/3a40462d-c790-4da4-b4ca-e999e2677bba) — classification: No Action Indicated (NAI), source: FDA, date: February 13, 2026
- [483 - KP Pharmaceutical Technology - 2024-03-21](https://www.keypedia.com/records/483/kp-pharmaceutical-technology/628e29b7-d44e-4256-871b-533310be9904) — source: FDA, date: March 21, 2024
- [483 - KP Pharmaceutical Technology - 2024-03-21](https://www.keypedia.com/records/483/kp-pharmaceutical-technology/c774dd17-c5c5-4769-9d75-e5911bfefd41) — source: FDA, date: March 21, 2024
- [FDA Inspection 1234088 - KP Pharmaceutical Technology - 2024-03-21](https://www.keypedia.com/records/fda_inspections/kp-pharmaceutical-technology/9de68d27-53a1-437c-bd52-951561889b31) — classification: Official Action Indicated (OAI), source: FDA, date: March 21, 2024
- [483 - KP Pharmaceutical Technology - 2024-03-11](https://www.keypedia.com/records/483/kp-pharmaceutical-technology/173fdef4-ac0a-4d24-b45a-3209f2cd0614) — source: FDA, date: March 11, 2024
- [483 - KP Pharmaceutical Technology - 2023-02-03](https://www.keypedia.com/records/483/kp-pharmaceutical-technology/af93ffc6-90c2-4cba-8eba-f8fa21b7a395) — source: FDA, date: February 3, 2023
- [FDA Inspection 1196557 - KP Pharmaceutical Technology - 2023-02-03](https://www.keypedia.com/records/fda_inspections/kp-pharmaceutical-technology/5548ae02-ff10-4eff-8460-ac8c20cfecd8) — classification: Official Action Indicated (OAI), source: FDA, date: February 3, 2023
- [FDA Inspection 1031466 - KP Pharmaceutical Technology - 2017-11-09](https://www.keypedia.com/records/fda_inspections/kp-pharmaceutical-technology/2d1a2289-0de3-49b4-b147-3a4a11798cc4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 9, 2017
- [FDA Inspection 940349 - KP Pharmaceutical Technology - 2015-05-21](https://www.keypedia.com/records/fda_inspections/kp-pharmaceutical-technology/07e6f536-5088-4142-806b-c7ca89668d42) — classification: No Action Indicated (NAI), source: FDA, date: May 21, 2015
- [FDA Inspection 814448 - KP Pharmaceutical Technology - 2012-12-17](https://www.keypedia.com/records/fda_inspections/kp-pharmaceutical-technology/4b9f3e27-c95e-49d0-8bdd-30a550539a53) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 17, 2012
- [FDA Inspection 709700 - KP Pharmaceutical Technology - 2011-01-25](https://www.keypedia.com/records/fda_inspections/kp-pharmaceutical-technology/35e31041-b581-4681-b162-301add4bfa76) — classification: No Action Indicated (NAI), source: FDA, date: January 25, 2011
- [FDA Inspection 614758 - KP Pharmaceutical Technology - 2009-09-22](https://www.keypedia.com/records/fda_inspections/kp-pharmaceutical-technology/257bf160-00e3-48de-9e1b-e07d1f9ac39c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 22, 2009

## Related Companies

- [AbbVie Ltd](https://www.keypedia.com/companies/abbvie-ltd/b07cdd9b-e7d5-4b8b-b31d-3cc5dd0c3775)
- [Somerset Therapeutics Limited](https://www.keypedia.com/companies/somerset-therapeutics-limited/cdfeb30a-e26b-4be1-9ca9-8aaf6434d0a7)
- [KVK Tech, Inc.](https://www.keypedia.com/companies/kvk-tech-inc/f8ea60fc-cfc0-4769-8e62-a677abd59cb9)
- [Pfizer Manufacturing Deutschland GmbH](https://www.keypedia.com/companies/pfizer-manufacturing-deutschland-gmbh/0847af94-33df-4d46-bba1-0c664ea47d08)
- [Pfizer Healthcare India Private Limited](https://www.keypedia.com/companies/pfizer-healthcare-india-private-limited/50c6f34f-3ef8-4cd6-bd55-6e1ee280d4f7)
- [Micro Labs Limited](https://www.keypedia.com/companies/micro-labs-limited/31ef3982-06b8-43c1-8e7e-585fb2dd02e7)
- [Corium Innovations, Inc.](https://www.keypedia.com/companies/corium-innovations-inc/6ef69358-81bb-44a9-a576-41a1c5d94783)
- [AMCOL Health & Beauty Solutions, Inc DBA AMCOL Household and Personal Care](https://www.keypedia.com/companies/amcol-health-beauty-solutions-inc-dba-amcol-household-and-personal-care/8e6cd831-d279-4916-bf97-b3f3713a5250)
- [Alliance Medical Products, Inc. DBA Siegfried Company](https://www.keypedia.com/companies/alliance-medical-products-inc-dba-siegfried-company/3daf2f25-e22a-41c0-bcd9-d0f8ef1ab602)
- [Llorens Pharmaceuticals International Division, Inc.](https://www.keypedia.com/companies/llorens-pharmaceuticals-international-division-inc/3bc4594c-275f-4451-9cf8-4e2e9bc14ee4)

## Related Officers

- [Investigator ](https://www.keypedia.com/people/logan-t-williams/a1febf59-970a-4e4e-9c0c-f4ad385582d7)
- [Investigator](https://www.keypedia.com/people/rafeeq-a-habeeb/ac58c0b7-bd42-4037-8ccb-bf0351b7744f)
- [President and CEO](https://www.keypedia.com/people/rajinder-p-mathura/06f10169-a154-46c8-98fb-89864ef07127)
- [Travis V. Hull](https://www.keypedia.com/people/travis-v-hull/1f3b5843-29ed-4291-8a8a-a2bf3ac36988)
- [Investigator?](https://www.keypedia.com/people/robert-j-ham/9146e819-4fce-420c-a722-cbe14e3c6afb)